1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Latin America (Brazil, Argentina, Chile, Mexico, Colombia, Venezuela) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant) Analysis And Segment Forecasts To 2020

The Latin America market for Insulin is expected to reach USD 3,760.7 million by 2020. Growing prevalence of diabetes (type I and type II) coupled with government initiatives to develop insulin in markets such as Brazil by providing medical and financial aid to the population in the form of subsidies and the entrance of multinational companies such as Novo Nordisk, Sanofi Aventis, etc is expected to drive regional insulin market. Affordability of medicines is perceived to be a key challenge for market development, as a significant part of the population may not be able to afford the product.

In 2013, Type II applications lead the regional market, with revenue of USD 1,183.7 million and are expected to grow at a CAGR of 15.8 % from 2014 to 2020. Type I applications are expected to have faster growth, at an estimated CAGR of 20.3 % from 2014 to 2020.

Further Key findings from the study suggest:

- Long acting products dominated insulin demand in Latin America, with estimated revenue of USD 548.6 million in 2013. Other leading products include rapid acting and premixed analogs, with the latter expected to grow at a CAGR of 14.3 % from 2014 to 2020.
- In 2013, Analog was a dominant insulin source and is expected to grow at a CAGR of 17.7 % from 2014 to 2020.
- R&D initiatives, changing lifestyle affecting health of people specially children and growing rate of old aged (above 40) population are also expected to have a positive influence on market demand.
- In 2013, Brazil was the largest regional insulin market in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR of 18.2 % from 2014 to 2020.
- Some of the key manufacturers in Latin American insulin market include Sanofi Aventis, Novo Nordisk, Nanjing Xinbai Pharmaceutical Co. Ltd, Takeda Pharmaceuticals, Eli Lilly and Company.

For the purpose of this study, Grand View Research has segmented the Asia Pacific Insulin market on the basis of product, application, source and region:

- Insulin Product Outlook
- Rapid acting
- Long acting
- Premixed
- Premixed analog
- Short acting
- Intermediate acting
- Insulin Application Outlook
- Type II and Other Diabetes
- Type I Diabetes
- Insulin Source Outlook
- Human Recombinant
- Analogs
- Insulin Regional Outlook
- Brazil
- Argentina
- Chile
- Mexico
- Colombia
- Venezuela
- Peru
- Rest of Latin America

Table Of Contents

Latin America (Brazil, Argentina, Chile, Mexico, Colombia, Venezuela) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I and II Diabetes, Analogs, Recombinant) Analysis And Segment Forecasts To 2020
Table of Contents

Chapter 1. Executive Summary

1.1. Latin America Insulin - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Latin America Insulin Industry Outlook

2.1. Market Segmentation

2.2. Market Size and Growth Prospects

2.3. Latin America Insulin Market Dynamics

2.3.1. Market Driver Analysis

2.3.2. Market Restraint Analysis

2.4. Key Opportunities Prioritized

2.5. Industry Analysis - Porter's

2.6. Latin America Insulin - Company Market Share Analysis

2.7. Latin America Insulin Market PESTEL Analysis, 2012

2.8. Latin America Insulin - Pipeline Overview

Chapter 3. Latin America Insulin Product Outlook

3.1. Rapid Acting Analog

3.1.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020

3.2. Short Acting Insulin

3.2.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020

3.3. Intermediate Acting Insulin

3.3.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020

3.4. Long Acting Analog

3.4.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020

3.5. Pre-Mixed

3.5.1.Pre-Mixed Insulin Market Estimates and Forecasts

3.5.1.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020

3.5.2.Pre-Mixed Analog Market Estimates and Forecasts

3.5.2.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020

Chapter 4. Latin America Insulin Segment Outlook

4.1. Insulin Analogs

4.1.1.Insulin Analogs Market Estimates and Forecasts

4.2. Human Recombinant Insulin

4.2.1. Human Recombinant Insulin Market Estimates and Forecasts

Chapter 5. Latin America Insulin Application Outlook

5.1. Type I and Other Diabetes

5.1.1. Type I and Other Diabetes Market Estimates and Forecasts

5.2. Type II Diabetes

5.2.1. Type II Diabetes Market Estimates and Forecasts

Chapter 6. Insulin Regional Outlook

6.1. Brazil

6.1.1. Brazil Insulin Market, by Products

6.1.2. Brazil Insulin Market, by Applications (only revenue)

6.1.3. Brazil Insulin Market, by Source

6.2. Argentina

6.2.1. Argentina Insulin Market, by Products

6.2.2. Argentina Insulin Market, by Applications (only revenue)

6.2.3. Argentina Insulin Market, by Source

6.3. Chile

6.3.1. Chile Insulin Market, by Products

6.3.2. Chile Insulin Market, by Applications (only revenue)

6.3.3. Chile Insulin Market, by Source

6.4. Mexico

6.4.1. Mexico Insulin Market, by Products

6.4.2. Mexico Insulin Market, by Applications (only revenue)

6.4.3. Mexico Insulin Market, by Source

6.5. Colombia

6.5.1. Colombia Insulin Market, by Products

6.5.2. Colombia Insulin Market, by Applications (only revenue)

6.5.3. Colombia Insulin Market, by Source

6.6. Venezuela

6.6.1. Venezuela Insulin Market, by Products

6.6.2. Venezuela Insulin Market, by Applications (only revenue)

6.6.3. Venezuela Insulin Market, by Source

6.7. Peru

6.7.1. Peru Insulin Market, by Products

6.7.2. Peru Insulin Market, by Applications (only revenue)

6.7.3. Peru Insulin Market, by Source

6.8. Rest of Latin America

6.8.1. Rest of Latin America Insulin Market, by Products

6.8.2. Rest of Latin America Insulin Market, by Applications (only revenue)

6.8.3. Rest of Latin America Insulin Market, by Source

Companies analyzed in competitive landscape

Novo Nordisk
Sanofi
Eli Lilly
Bristol-Myers Squibb
Novartis
Takeda Pharmaceuticals
Boehringer Ingelheim
Biocon
Dongbao Enterprise Group Co., Ltd.
Merck KGaA
Oramed Pharmaceuticals Inc.
Halozyme Therapeutics
Wanbang Biopharma
Xinbai Pharmaceutical
Gan and Lee Pharmaceutical
Sandoz
Amega Biotech
Biosidus
Sinergium Biotech
Probiomed
EMS Farma.

List of Tables

Latin America Insulin- Industry summary andCritical Success Factors (CSFs)
Latin America Insulin Market, by Countries, 2012 - 2020 (USD Million)
Latin America Insulin Market, by Products, 2012 - 2020 (USD Million)
Latin America Insulin Market, by Products, 2012 - 2020 (‘000 Units)
Latin America Insulin Market, by Applications, 2012 - 2020 (USD Million)
Latin America Insulin Market, by Source Types, 2012 - 2020 (USD Million)
Latin America Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Brazil Insulin Market, by Products, 2012 - 2020 (USD Million)
Brazil Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Brazil Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Brazil Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Brazil Insulin Market, by Source Types, 2012 - 2020 (USD million)
Brazil Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Brazil Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Argentina Insulin Market, by Products, 2012 - 2020 (USD Million)
Argentina Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Argentina Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Argentina Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Argentina Insulin Market, by Source Types, 2012 - 2020 (USD million)
Argentina Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Argentina Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Chile Insulin Market, by Products, 2012 - 2020 (USD Million)
Chile Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Chile Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Chile Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Chile Insulin Market, by Source Types, 2012 - 2020 (USD million)
Chile Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Chile Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Mexico Insulin Market, by Products, 2012 - 2020 (USD Million)
Mexico Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Mexico Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Mexico Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Mexico Insulin Market, by Source Types, 2012 - 2020 (USD million)
Mexico Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Mexico Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Colombia Insulin Market, by Products, 2012 - 2020 (USD Million)
Colombia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Colombia Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Colombia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Colombia Insulin Market, by Source Types, 2012 - 2020 (USD million)
Colombia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Colombia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Venezuela Insulin Market, by Products, 2012 - 2020 (USD Million)
Venezuela Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Venezuela Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Venezuela Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Venezuela Insulin Market, by Source Types, 2012 - 2020 (USD million)
Venezuela Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Venezuela Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Peru Insulin Market, by Products, 2012 - 2020 (USD Million)
Peru Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Peru Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Peru Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Peru Insulin Market, by Source Types, 2012 - 2020 (USD million)
Peru Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Peru Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Rest of Latin America Insulin Market, by Products, 2012 - 2020 (USD Million)
Rest of Latin America Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Rest of Latin America Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
Rest of Latin America Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Rest of Latin America Insulin Market, by Source Types, 2012 - 2020 (USD million)
Rest of Latin America Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Rest of Latin America Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)

List of Figures

Latin America Insulin Market Segmentation
Latin America Insulin Market Revenue, 2012 - 2020
Latin America Insulin Market Dynamics
Latin America Insulin Company Market Share Analysis, 2012
Key Opportunities Prioritized
Industry Analysis - Porter's
Latin America Insulin PESTEL Analysis, 2012
Latin America Insulin market - company market share analysis, 2013 (%)
Latin America insulin market, by product type, 2012 - 2020
Latin America insulin market, by source types, 2012 - 2020
Latin America insulin market, by applications, 2012 - 2020

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Type 2 Diabetes Mellitus: KOL Insight 2016

Type 2 Diabetes Mellitus: KOL Insight 2016

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Can top-ranked GLP1 agonists move out of the third-line setting? GLP1 agonists may be the top-ranked type 2 diabetes mellitus (T2DM) treatment according to the American Association of Clinical Endocrinologists ...

European Market Report for Modern Insulin 2016 - MedCore

European Market Report for Modern Insulin 2016 - MedCore

  • $ 5995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern ...

US Market Report for Insulin 2017 - MedCore

US Market Report for Insulin 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The U.S. insulin market can be segmented by insulin type, yielding four segments: long-acting insulin, rapid-acting insulin, premixed insulin and human insulin. In 2016, the largest segment ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.